Table 1.
Long COVID symptoms as reported in various studies
| Patient’s characteristic | Studies | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Carfi et al. [17] | Garrigues et al. [18] | Huang et al. [19] | Moreno-Pérez et al. [5] | Mandal et al. [6] | Goërtz et al. [20] | Peghin et al. [21] | Sykes et al. [22] | Augustin et al. [23] | Lopez-Leon et al. [16] | |
| Total participants | 143 | 120 | 1733 | 277 | 384 | 2159 | 599 | 134 | 353 | 47,910 |
|
Study type Patient group Hospitalised or non-hospitalised or both |
Survey Discharged from hospital |
Survey Discharged from hospital |
Survey/assessment Discharged from hospital |
Survey/assessment Both |
Cross-sectional Discharged from hospital |
Survey Both |
Prospective study Both |
Prospective study Discharged from hospital |
Prospective study Both |
Systematic review and meta-analysis |
| Mean age in years | 56.5 | 63.2 | 57 (median) | 62(median) | 59.9 | 47 | 53 | 58 (median) | 43 (median) | |
| Male: female ratio | 63:37 | 62.5:37.5 | 52:48 | 53:47 | 62:38 | 15:85 | 47:53 | 66:34 | 43:57 | |
| Hospital stay in days | 13.5 | 13.4 | 14(median) | 8.5 median | 6.5 | NA | 7 median | 7 | NA | |
| Mean follow up in days | 60.3 | 110.9 | 186(median) | 77 | 54 (median) | 79 | 191 (median) | 113( median) | 207(median) | |
| Long COVID symptoms in % | ||||||||||
| Fatigue | 53.1 | 55 | 63 | 34.8 | 69 | 87 | 13.1 | 39.6 | 14.2 | 55 |
| Dyspnoea | 43.4 | 41.7 | 26 | 34.4 | 53 | 71 | 6 | 59.7 | 13.6 | 24 |
| Arthralgia | 27.3 | NA | 9 | 19.6* | NA | 27 | NA | NA | NA | 19 |
| Chest pain | 21.7 | 10.8 | 5 | NA | NA | 44 | 0.8 | 17.9 | NA | 16 |
| Cough | 15.7* | 16.7 | NA | 21.3 | 34 | 29 | 2 | 35.1 | 4.2 | 19 |
| Anosmia | 15* | 13.3% | 11 | NA | NA | 13 | NA | 9.7 | 14.7 | 21 |
| Sicca Symptoms | 14.28* | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Dysgesia | 10* | 10.8 | 7 | 21.4** | NA | 11 | NA | NA | 11.0 | 23 |
| Headache | NA | NA | 2 | 17.8 | NA | 38 | 2.7 | NA | 3.7 | 44 |
| Sore throat | NA | NA | 4 | NA | NA | 26 | NA | NA | NA | NA |
| Myalgia | 5.71* | 15.8 | 2 | NA | NA | 36 | NA | 51.5 | 3.1 | NA |
| Diarrhoea | 2.85* | 24.2 | 5 | 10.5 | NA | 10 | NA | NA | 1.1 | NA |
| Skin rashes | NA | NA | 3 | 8.3 | NA | 2 | 3.4 | NA | NA | 12 |
| Sleep disorder | NA | 30.8 | 26 | NA | NA | NA | NA | 35.1 | NA | 11 |
| Hair Loss | NA | 20 | 22 | NA | NA | NA | 3.7 | NA | 2.5 | 25 |
| Palpitation | NA | NA | 9 | NA | NA | 32 | NA | NA | NA | 11 |
| Anxiety or depression^ | NA | NA | 23 | NA | 14.6^ | NA | NA | 47.8 | NA | 13 |
| Memory loss/impairment | NA | 34 | NA | NA | NA | NA | NA | 37.3 | NA | 16 |
NA not available
*Includes myalgia, **includes anosmia